default author photo

Robert Soiffer

Harvard University - Dana-Farber Cancer Institute

450 Brookline Avenue

Boston, MA 02215

United States

SCHOLARLY PAPERS

1

DOWNLOADS

156

TOTAL CITATIONS

2

Scholarly Papers (1)

1.

A Phase 3 Study of Remestemcel-L versus Placebo Added to Second Line Therapy in Patients with Steroid Refractory Acute Graft Versus Host Disease

Number of pages: 31 Posted: 19 Mar 2019
University of Texas at Houston - MD Anderson Cancer Center, Mesoblast, University of Calgary - Tom Baker Cancer Center, Karmanos Cancer Institute, University Hospitals Bristol, Harvard University - Dana-Farber Cancer Institute, Emory University - Emory University Hospital, Mesoblast, Mesoblast, University of Texas at Houston - MD Anderson Cancer Center and Fred Hutchinson Cancer Research Center
Downloads 156 (477,517)
Citation 2

Abstract:

Loading...

mesenchymal stem cells, acute graft-versus-host disease, allogeneic hematopoietic cell transplantation